Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Biotech
US biotechs thinking twice about licensing drugs to Europe
U.S. biotechs are increasingly reluctant to license their drugs to European partners in order to avoid becoming a target of the Trump administration.
James Waldron
Sep 26, 2025 8:09am
Fierce Pharma
Nominations open for Fiercest Women in Life Sciences—LAST DAY
Sep 26, 2025 7:00am
Merck opts in on Evaxian's preclinical vaccine candidate
Sep 25, 2025 7:00am
Biopharma biobucks decline, while upfront deal payments rise
Sep 24, 2025 11:30am
Harmony's pivotal trial flops as placebo response causes discord
Sep 24, 2025 9:35am
uniQure plans FDA push after Huntington's gene therapy trial win
Sep 24, 2025 9:20am
